{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:23:54Z","timestamp":1794025434991,"version":"4.8.0"},"reference-count":54,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,11,1]]},"DOI":"10.2169\/internalmedicine.6818-25","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:09:30Z","timestamp":1773094170000},"page":"2905-2911","source":"Crossref","is-referenced-by-count":0,"title":["Cancer-associated Thrombosis Presenting as Multiple Brain Infarctions during Complete Remission of Follicular Lymphoma"],"prefix":"10.2169","volume":"65","author":[{"given":"Taichiro","family":"Tokura","sequence":"first","affiliation":[{"name":"Department of Hematology, Tokyo Metropolitan Tama-Hokubu Medical Center, Japan"},{"name":"Department of Hematology, Nippon Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tokyo Metropolitan Tama-Hokubu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youhei","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tokyo Metropolitan Tama-Hokubu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reina","family":"Saga","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tokyo Metropolitan Tama-Hokubu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Hidai","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tokyo Metropolitan Tama-Hokubu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayuri","family":"Motomura","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tokyo Metropolitan Tama-Hokubu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tsantes AG, Petrou E, Tsante KA, et al. Cancer-associated thrombosis: pathophysiology, laboratory assessment, and current guidelines. Cancers (Basel) 16: 2082, 2024.","DOI":"10.3390\/cancers16112082"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Alshehri FS, Alloghbi A, Alshalani A, Sabah HA, Whyte CS. Cancer-Associated Thrombosis (CAT); mechanisms and treatment options. Thromb J 23: 116, 2025.","DOI":"10.1186\/s12959-025-00795-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Falanga A, Marchetti M. Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity. J Thromb Haemost 21: 1397-1408, 2023.","DOI":"10.1016\/j.jtha.2023.02.029"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Grilz E, Posch F, Nopp S, et al. Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer - a nationwide analysis. Eur Heart J 42: 2299-2307, 2021.","DOI":"10.1093\/eurheartj\/ehab171"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hamza MS, Mousa SA. Cancer-associated thrombosis: risk factors, molecular mechanisms, future management. Clin Appl Thromb Hemost 26: 1076029620954282, 2020.","DOI":"10.1177\/1076029620954282"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Abdol Razak NB, Jones G, Bhandari M, Berndt MC, Metharom P. Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment. Cancers (Basel) 10: 380, 2018.","DOI":"10.3390\/cancers10100380"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Chew HK, Wun T, Harvey D, Zhou H, White RH. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 166: 458-464, 2006.","DOI":"10.1001\/archinte.166.4.458"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Cohen AT, Katholing A, Rietbrock S, Bamber L, Martinez C. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study. Thromb Haemost 117: 57-65, 2017.","DOI":"10.1160\/TH15-08-0686"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sevestre MA, Soudet S. Epidemiology and risk factors for cancer-associated thrombosis. J Med Vasc 45: 6S3-6S7, 2020.","DOI":"10.1016\/S2542-4513(20)30513-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Horsted F, West J, Grainge MJ. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med 9: e1001275, 2012.","DOI":"10.1371\/journal.pmed.1001275"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Gade IL, Braekkan SK, Naess IA, et al. The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort. J Thromb Haemost 15: 1567-1575, 2017.","DOI":"10.1111\/jth.13752"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Dickmann B, Ahlbrecht J, Ay C, et al. Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study. Haematologica 98: 1309-1314, 2013.","DOI":"10.3324\/haematol.2012.073338"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Khorana AA, Mackman N, Falanga A, et al. Cancer-associated venous thromboembolism. Nat Rev Dis Primers 8: 11, 2022.","DOI":"10.1038\/s41572-022-00336-y"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Mulder FI, Horv\u00e1th-Puh\u00f3 E, van Es N, et al. Venous thromboembolism in cancer patients: a population-based cohort study. Blood 137: 1959-1969, 2021.","DOI":"10.1182\/blood.2020007338"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mahajan A, Brunson A, Adesina O, Keegan THM, Wun T. The incidence of cancer-associated thrombosis is increasing over time. Blood Adv 6: 307-320, 2022.","DOI":"10.1182\/bloodadvances.2021005590"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Martens KL, Li A, La J, et al. Epidemiology of cancer-associated venous thromboembolism in patients with solid and hematologic neoplasms in the veterans affairs health care system. JAMA Netw Open 6: e2317945, 2023.","DOI":"10.1001\/jamanetworkopen.2023.17945"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM. Stroke in patients with cancer: incidence and etiology. Neurology 62: 2025-2030, 2004.","DOI":"10.1212\/01.WNL.0000129912.56486.2B"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Key NS, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update. J Clin Oncol 41: 3063-3071, 2023.","DOI":"10.1200\/JCO.23.00294"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Falanga A, Ay C, Di Nisio M, et al.; the ESMO Guidelines Committee. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline. Ann Oncol 34: 452-467, 2023.","DOI":"10.1016\/j.annonc.2022.12.014"},{"key":"20","unstructured":"20. Streiff MB, Holmstrom B, Angelini D, et al. Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 19: 1181-1201, 2021."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lyman GH, Carrier M, Ay C, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv 5: 927-974, 2021.","DOI":"10.1182\/bloodadvances.2021004734"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Carney BJ, Wang TF, Ren S, et al.; the VENUS Network Investigators. Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study. Blood Adv 5: 5546-5553, 2021.","DOI":"10.1182\/bloodadvances.2021005966"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Zaorsky NG, Churilla TM, Egleston BL, et al. Causes of death among cancer patients. Ann Oncol 28: 400-407, 2017.","DOI":"10.1093\/annonc\/mdw604"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Wang TF, Luo S, Gage BF, et al. Association between anticoagulant-related bleeding and mortality in patients with hematological malignancies and cancer-associated venous thromboembolism. Thromb Res 248: 109284, 2025.","DOI":"10.1016\/j.thromres.2025.109284"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nouh AM, Staff I, Finelli PF. Three Territory Sign: An MRI marker of malignancy-related ischemic stroke (Trousseau syndrome). Neurol Clin Pract 9: 124-128, 2019.","DOI":"10.1212\/CPJ.0000000000000603"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Varki A. Trousseau&apos;s syndrome: multiple definitions and multiple mechanisms. Blood 110: 1723-1729, 2007.","DOI":"10.1182\/blood-2006-10-053736"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Samuelson Bannow BT, Lee A, Khorana AA, et al. Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH. J Thromb Haemost 16: 1246-1249, 2018.","DOI":"10.1111\/jth.14015"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. MacDougall K, Chukkalore D, Rehan M, Kashi M, Bershadskiy A. Acute promyelocytic leukemia presenting as recurrent venous and arterial thrombotic events: a case report and review of the literature. J Community Hosp Intern Med Perspect 11: 832-838, 2021.","DOI":"10.1080\/20009666.2021.1973657"},{"key":"29","unstructured":"29. Zhao C, Xie X, Ge D, et al. Cerebral infarction as the first symptom in acute promyelocytic leukemia: a case report and literature review. Zhong Nan Da Xue Xue Bao Yi Xue Ban 45: 476-480, 2020."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Fuh B, Lurito J, Grossi M, Daeschner C, Russo S. Bilateral internal carotid artery occlusions in a pediatric patient with refractory acute myeloid leukemia. Pediatr Blood Cancer 54: 770-772, 2010.","DOI":"10.1002\/pbc.22432"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Arnaout MK, Tamburro RF, Bodner SM, et al. <i>Bacillus cereus<\/i> causing fulminant sepsis and hemolysis in two patients with acute leukemia. J Pediatr Hematol Oncol 21: 431-435, 1999.","DOI":"10.1097\/00043426-199909000-00018"},{"key":"32","unstructured":"32. Chen CY, Zimmerman RA, Faro S, Bilaniuk LT, Chou TY, Molloy PT. Childhood leukemia: central nervous system abnormalities during and after treatment. AJNR Am J Neuroradiol 17: 295-310, 1996."},{"key":"33","unstructured":"33. Watanabe I, Sakai I, Matsumoto I. Superior sagittal sinus thrombosis following L-asparaginase therapy of acute lymphoblastic leukemia. Rinsho Ketsueki (Jpn J Clin Hematol) 33: 343-348, 1992."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Corroza J, Alburquerque C, Mart\u00ednez-Mart\u00ednez L, et al. A single institution series of intravascular lymphoma: neurological manifestations and neuroimaging findings. Neurologia (Engl Ed) 40: 768-776, 2025.","DOI":"10.1016\/j.nrl.2023.11.009"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Cheewadhanaraks S, Rapalino O. Conventional and advanced imaging features of CNS intravascular lymphoma. J Neuroimaging 35: e70061, 2025.","DOI":"10.1111\/jon.70061"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Takaku N, Hayashi K, Sato M, et al. Intravascular large B-cell lymphoma diagnosed after recurrent stroke: case report and literature review. Neurol Int 17: 68, 2025.","DOI":"10.3390\/neurolint17050068"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Oka T, Tsuji Y, Sakai T, et al. Intervascular large B-cell lymphoma with severe anemia and a high-titer of cold agglutinin. Intern Med 64: 3279-3283, 2025.","DOI":"10.2169\/internalmedicine.5340-25"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Liu J, Cheng CL, Koh M. Intravascular Large B-cell Lymphoma in a young southeast Asian male with recurrent strokes and pulmonary ground glass opacities with a normal chest radiograph. Cureus 16: e66112, 2024.","DOI":"10.7759\/cureus.66112"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Murakami Y, Hattori S, Hayashi S, et al. Renal intravascular large B-cell lymphoma predominantly localized in peritubular capillaries. CEN Case Rep 10: 383-387, 2021.","DOI":"10.1007\/s13730-020-00570-x"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Sugiyama A, Kobayashi M, Daizo A, et al. Diffuse cerebral vasoconstriction in a intravascular lymphoma patient with a high serum MPO-ANCA level. Intern Med 56: 1715-1718, 2017.","DOI":"10.2169\/internalmedicine.56.8051"},{"key":"41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jha2.837","volume":"5","author":"W Kitamura","year":"2023","unstructured":"41. Kitamura W, Sato Y, Kuyama S. Trousseau&apos;s syndrome in diffuse large B-cell lymphoma. EJHaem 5: 271-273, 2023.","journal-title":"eJHaem","ISSN":"https:\/\/id.crossref.org\/issn\/2688-6146","issn-type":"print"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Uchida T, Amagasaki K, Hosono A, Nakaguchi H. Primary diffuse large B-cell lymphoma of the cranial vault with Trousseau syndrome: a case report. J Med Case Rep 15: 431, 2021.","DOI":"10.1186\/s13256-021-02979-z"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Wang LX, Yu XQ, Cao J, et al. Bilateral anterior cerebral artery occlusion following CD19- and BCMA-targeted chimeric antigen receptor T-cell therapy for a myeloma patient. Int J Hematol 114: 408-412, 2021.","DOI":"10.1007\/s12185-021-03160-4"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. de Celis E, Alonso de Leci\u00f1ana M, Rodr\u00edguez-Pardo J, Fuentes B, D\u00edez-Tejedor E. Increased risk of ischemic stroke in multiple myeloma associated with lenalidomide treatment: a case report and review of the literature. Clin Neuropharmacol 41: 232-235, 2018.","DOI":"10.1097\/WNF.0000000000000310"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Zhao X, Pan Y, Ren W, et al. Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis. Cancer Sci 109: 403-411, 2018.","DOI":"10.1111\/cas.13475"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Lindholm A, Abrahamsen ML, Buch-Larsen K, et al. Pro-inflammatory cytokines increase temporarily after adjuvant treatment for breast cancer in postmenopausal women: a longitudinal study. Breast Cancer Res 26: 142, 2024.","DOI":"10.1186\/s13058-024-01898-3"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Kim TY, Gu JY, Jung HS, Koh Y, Kim I, Kim HK. Elevated extracellular trap formation and contact system activation in acute leukemia. J Thromb Thrombolysis 46: 379-385, 2018.","DOI":"10.1007\/s11239-018-1713-3"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Al-Ani F, Wang YP, Lazo-Langner A. Development of a clinical prediction rule for venous thromboembolism in patients with acute leukemia. Thromb Haemost 120: 322-328, 2020.","DOI":"10.1055\/s-0039-3400303"},{"key":"49","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1055\/a-2207-7715","volume":"8","author":"M Shoji","year":"2024","unstructured":"49. Shoji M, Yamashita Y, Ishii M, et al.; J-Khorana Registry Investigators. A Predictive model for cancer-associated thrombosis in Japanese cancer patients: findings from the J-Khorana Registry. TH Open 8: e9-e18, 2024.","journal-title":"TH Open","ISSN":"https:\/\/id.crossref.org\/issn\/2512-9465","issn-type":"print"},{"key":"50","doi-asserted-by":"publisher","unstructured":"50. Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111: 4902-4907, 2008.","DOI":"10.1182\/blood-2007-10-116327"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Th\u00e5lin C, Demers M, Blomgren B, et al. NETosis promotes cancer-associated arterial microthrombosis presenting as ischemic stroke with troponin elevation. Thromb Res 139: 56-64, 2016.","DOI":"10.1016\/j.thromres.2016.01.009"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Park J, Wysocki RW, Amoozgar Z, et al. Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. Sci Transl Med 8: 361ra138, 2016.","DOI":"10.1126\/scitranslmed.aag1711"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Rosell A, Martinod K, Mackman N, Th\u00e5lin C. Neutrophil extracellular traps and cancer-associated thrombosis. Thromb Res 213 (Suppl 1): S35-S41, 2022.","DOI":"10.1016\/j.thromres.2021.12.018"},{"key":"54","doi-asserted-by":"crossref","first-page":"e22946","DOI":"10.4161\/onci.22946","volume":"2","author":"M Demers","year":"2013","unstructured":"54. Demers M, Wagner DD. Neutrophil extracellular traps: a new link to cancer-associated thrombosis and potential implications for tumor progression. Oncoimmunology 2: e22946, 2013.","journal-title":"OncoImmunology","ISSN":"https:\/\/id.crossref.org\/issn\/2162-4011","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/21\/65_6818-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:33:30Z","timestamp":1794022410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/21\/65_6818-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11,1]]},"references-count":54,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6818-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,11,1]]},"article-number":"6818-25"}}